1-11 of 11
Jennifer Willert
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Durable Responses in Relapsed/Refractory (r/r) ALL, DLBCL, and FL Patients Treated with Tisagenlecleucel and Its Association with Persistence of CAR T-Cells

Rakesh Awasthi, Edward Waldron, Stephan Grupp, Michael A. Pulsipher, Peter Bader, Stephen J Schuster, Richard T Maziarz, Edmund K. Waller, Ulrich Jaeger, Catherine Thieblemont, Martin Dreyling, Nathan Fowler, Harald Jakob Maier, Jennifer Willert
Journal: Blood
Blood (2023) 142 (Supplement 1): 4872.
https://doi.org/10.1182/blood-2023-181663
Published: 2023
Journal Articles

Real-World Outcomes for Pediatric and Young Adult Patients with Relapsed or Refractory (R/R) B-Cell Acute Lymphoblastic Leukemia (ALL) Treated with Tisagenlecleucel: Update from the Center for International Blood and Marrow Transplant Research (CIBMTR) Registry

Samuel John, Michael A. Pulsipher, Amy Moskop, Zhen-Huan Hu, Christine L. Phillips, Erin Marie Hall, Steven P. Margossian, Sarah Nikiforow, Paul L. Martin, Benjamin Oshrine, Amy K. Keating, Rayne H. Rouce, Ranjan Tiwari, Santiago Redondo, Jennifer Willert, Abhijit Agarwal, Marcelo C Pasquini, Stephan A. Grupp
Journal: Blood
Blood (2021) 138 (Supplement 1): 428.
https://doi.org/10.1182/blood-2021-146393
Published: 2021
Journal Articles

Tisagenlecleucel Leukapheresis and Manufacturing Outcomes in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia

Jennifer Willert, David Fong, Lee Clough, Andrea Magley, Ali Shojaee, Ranjan Tiwari, Christopher Acker
Journal: Blood
Blood (2021) 138 (Supplement 1): 3882.
https://doi.org/10.1182/blood-2021-144939
Published: 2021
Journal Articles

HESTER: A Phase II Study Evaluating Efficacy and Safety of Tisagenlecleucel Reinfusion in Pediatric and Young Adult Patients with Acute Lymphoblastic Leukemia Experiencing Loss of B-Cell Aplasia

Michael W Boyer, MD, Sonali Chaudhury, MBBS,MD, Kara L Davis, DO, Timothy Alan Driscoll, MD, Stephan A Grupp, MD PhD, Michelle Hermiston, MD PhD, Samuel John, MD, Amy K Keating, MD PhD, Christina Kovacs, BS, JD, Andrea Magley, BS, Gary Douglas Myers, MD, Christine L Phillips, MD, Michael A Pulsipher, MD, Das Purkayastha, PhD, Julie-An Talano, MD, Jennifer Willert, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-136340
Published: 2020
Journal Articles

Tisagenlecleucel Manufacturing Feasibility in Patients Less Than 3 Years of Age with Relapsed/Refractory Acute Lymphoblastic Leukemia

Lamis K. Eldjerou, MD, Christopher Acker, BS, Damien Howick, MSc, Lee Clough, RN, Miriam Fuchs, MD PhD, Florence Salmon, PhD, Jennifer Willert, MD, Ranjan Tiwari, MSc, Mayo Pujols, MS, Matthew Robson, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5066.
https://doi.org/10.1182/blood-2019-127346
Published: 2019
Journal Articles

Azacitidine Administration Following Hematopoietic Stem Cell Transplantation Is Safe and Feasible in Children with Acute Leukemia

Justin T. Wahlstrom, MD, Biljana N. Horn, MD, Carol Fraser-Browne, Rebecca Hoeweler, Ying Lu, PhD, Alexis Melton, MD PhD, Jennifer Willert, MD, Christopher C. Dvorak, MD
Journal: Blood
Blood (2016) 128 (22): 4805.
https://doi.org/10.1182/blood.V128.22.4805.4805
Published: 2016
Journal Articles

Daratumumab Is Effective in the Treatment of Refractory Post-Transplant Autoimmune Hemolytic Anemia: A Pediatric Case Report

Vanessa P. Tolbert, MD, Robert Goldsby, MD, James Huang, MD, Kristin Shimano, MD, Alexis Melton, MD PhD, Jennifer Willert, MD, Biljana N. Horn, MD, Christopher C. Dvorak, MD, Justin T. Wahlstrom, MD
Journal: Blood
Blood (2016) 128 (22): 4819.
https://doi.org/10.1182/blood.V128.22.4819.4819
Published: 2016
Journal Articles

Non-Myeloablative Conditioning Targeting Host Immunosuppression Is Successful in Matched Sibling Donor Stem Cell Transplantation for Hemoglobinopathies in Children

Allison A King, MD MPH, Nancy Bunin, MD, Indira Sahdev, MBBS, Joel A Brochstein, MD FAAP, Allistair Abraham, MD, Jacqueline Dioguardi, PA-C, Naynesh R. Kamani, MD, Eric Jon Anderson, MD, Jennifer Willert, MD, Ka Wah Chan, MD, Michael Grimley, MD, Dorothea N. Douglas, MBBS, Roberta H. Adams, MD, Sonali Chaudhury, MD, Lolie C. Yu, MD, Andrew Gilman, MD, Martin Andreansky, MD PhD, Geoff D. E. Cuvelier, MD FRCP(C), Alfred P. Gillio, MD, Kimberly A. Kasow, D.O., Paul R. Haut, MD, Gregory A. Hale, MD, Jignesh Dalal, MD, Akshat Jain, MD MPH, MBBS, Eric Hanson, Lisa. Murray, BS, Shalini Shenoy, MD
Journal: Blood
Blood (2014) 124 (21): 3873.
https://doi.org/10.1182/blood.V124.21.3873.3873
Published: 2014
Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD
Journal: Blood
Blood (2008) 112 (11): 4393.
https://doi.org/10.1182/blood.V112.11.4393.4393
Published: 2008
Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD
Journal: Blood
Blood (2008) 112 (11): 4399.
https://doi.org/10.1182/blood.V112.11.4399.4399
Published: 2008
Journal Articles

Hematopoietic Stem Cell Transplantation from Sibling or Autologous Cord Blood Units: Report from a Single Cord Blood Unit (CBU) Bank.

Jennifer Willert, MD, Heather Brown, MS, Denise LaBossierre, RN, Joseph Rosenthal, MD
Journal: Blood
Blood (2007) 110 (11): 3329.
https://doi.org/10.1182/blood.V110.11.3329.3329
Published: 2007